Schedule 13D ownership disclosure
Coherus Oncology Inc
Security class unavailable · CUSIP: 19249H103
Event date: 2016-08-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,893,221
- Percent of class
- 6.6700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-16-122921
- Form type
- SC 13D
- Filer
- Coherus Oncology, Inc.
- CIK
- CIK 1512762
- Filed
- Sep 07, 2016
- Reporting period
- Aug 26, 2016
- Description
- Schedule 13D beneficial ownership